Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study

BACKGROUND: The survival advantage of postoperative chemotherapy for high-risk stage II colon cancer (CC) patients remains unclear. OBJECTIVES: The purpose was to evaluate the survival of high-risk stage II CC cases treated with chemotherapy and to construct survival prediction models to predict the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lin-Lin, Xiang, Zuo-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706075/
https://www.ncbi.nlm.nih.gov/pubmed/36458048
http://dx.doi.org/10.1177/17562848221137758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706075/
https://www.ncbi.nlm.nih.gov/pubmed/36458048
http://dx.doi.org/10.1177/17562848221137758

Ejemplares similares